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: To screen non-diabetic hypertensive Nigerian patients with a view to determining their
haematological and coagulation profiles.
Thirty (30) consecutive non-diabetic hypertensive patients, aged 20-60 years and 30
age and sex-matched, apparently healthy subjects, were investigated for some haematological and coagulation
parameters, blood pressure, pulse, body weight, height and body mass index.
There were statistically significant differences (p<0.05), in some haematological parameters, blood
pressure, body mass index and height in the total number of patients studied when compared with the total
control group. The separate genders each showed statistically significant differences in both haematological
parameters and blood pressure (P<0.05) when compared with their corresponding control groups. In addition,
haematological values, body mass index and height showed statistically significant differences (p<0.05) when
the male and female patients were compared. Overall, 25 (83.33%) of the patient's blood films were
normochromic and normocytic.
It appears that hypertension has adverse effects on haematological parameters. We therefore
recommended that coagulations studies should be included in the investigation work-up of hypertensive
patients.
Prothrombin Time, Activated Partial Thromboplastin Time, Haematological Parameters, Non-
diabetic Hypertensives.
INTRODUCTION
Cardiovascular disease is the main cause of death in
the developed world , and there is growing evidence
that a similar epidemic is inevitable for the
developing world, if current trends continue
unchecked . Hypertension has for long been globally
recognized as the most prevalent cardiovascular
disease and is an acknowledged potent risk factor in
the development of such disease outcomes as
coronary heart disease, stroke, congestive heart
failure and renal insufficiency. A direct positive
relationship between blood pressure and
cardiovascular risk has long been established . This
relationship is strong, continuous, graded,
consistent , independent, predictive, and
etiologically significant for those with and without
coronary heart disease ; it has been identified in both
males and females, younger and older adults,
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countries; and applies to those within high-normal
blood pressure as well as those with hypertension .
After adjusting for age and in line with the revised
criteria by the World Health Organization (WHO,
1999) , an overall 16.6% or 7.8million of the
46.91million Nigerian population aged 15years and
above were believed to be hypertensive. Patients with
hypertension have a tendency to die prematurely; the
most common cause of death being heart disease,
stroke , and/or renal failure . The health burden in
Nigeria (the index country of study) resulting from
hypertension is quite considerable .
Newly recognized risk factors that influence the
development of cardiovascular disease include
polymorphisms in the gene that encode fibrinogen
and platelet glycoprotein II /III receptors.
Specifically, a positive association exists between
polymorphisms in the fibrinogen B 448 and platelet
glycoprotein III P1 genes and the extent of coronary
artery disease . Transient thrombosis and vaso-
constriction cause unstable angina. Platelet-initiated










were divided into two equal groups of fifteen (15)
males and females respectively. Two control groups
of 15 males and 15 females were also studied. This
brought the total number of subjects studied to sixty
(60).
History was taken from the patients, after which
clinical examination was done, in order to establish
the diagnosis of hypertension, by one of the authors, a
cardiologist. Biodata and clinical parameters were
recorded.
Routine chest radiograph, serum electrolytes, blood
urea and creatinine, fasting blood glucose and
urinalysis were carried out to rule out the exclusion
criteria indices.
Necessary haematological tests were then done,
employing standard manual methods with
appropriate controls in all laboratory investigations.
On enrolment of the non-diabetic
hypertensive cases, suitable controls were identified.
These were matched to the patients in age and sex and
were not hypertensive. These control subjects
included volunteering students, hospital staff and
other patients undergoing a clinical check up and
found to be healthy.
Physical age, sex, height, heart rate and blood
pressure recordings were done.
Heamatological profile Haemoglobin (Hb),
packed cell volume (PCV), Mean corpuscular
haemoglobin concentration (MCHC), platelet
count, erythrocyte sedimentation rate (ESR),
Total and differential white blood cell count,
such as neutrophils, lymphocytes, eosinophils,
monocytes, and basophils, prothrombin time
(PT) and Activated partial thromboplastin time
(APTT).
Data analysis was by computer, using EPI Info
(version 6) statistical software. Data Storage was in
Microsoft Word XP2000.
Data are expressed as mean (standard deviation). P.
values less than 0.05 were regarded as significant.
Figure 1 shows that there were 30 males and 30
females, with male, female ratio 1:1. The ages ranged
from 20 to 60 years with mean 44.3. The 41 50 aged
group recorded the highest number of subjects.
There were statistical differences (p<0.05) in Hb.
PCV, platelet, ESR, total WBC, neutrophil,
lymphocyte, and monocyte counts, PT, APTT, BP,
height and BMI in the patients when compared with











7Nigerian Journal of Clinical Practice March 2009, Vol.12(1) Prothrombin Time Ukaejiofo et al
8Nigerian Journal of Clinical Practice March 2009, Vol.12(1) Prothrombin Time Ukaejiofo et al
There were also statistical differences (p<0.05) in
Hb, PCV, ESR, lymphocyte, eosinophil, monocyte
counts, PT and BP in the male patients when
compared with the male controls (table 2).
Table 3 reveals statistical significant differences in
Hb, ESR neutrphil, eosinophil counts, BP, height and
BMI (p<0.05) in the female patients when compared
to the corresponding females control.
The lymphocyte, monocyte counts, height and BMI
indices showed statistically significant differences
(p<0.05) when the male and female patients were
compared (table 4).
Overall 25 (83.33%) of the non-diabetic
hypertensive patients blood film showed normal
(normochromic and normocytic) blood picture.
Figure 1:
Table 1:
P- Value when compared with the control group: p
Age and Sex Distribution of Subjects.
Comparison between the Patients with
the Control (Non-Diabetic Hypertensive) Group.
*
Table 2:
P-Value when compared with control group * P <
0.01, ** P< 0.001, *** P< 0.0001
Table 3:
P-value * = P<0.01, ** = P< 0.001, *** = P<
0.0001
Comparison between the Male Patients
with Male Controls.




P-value * = P<0.01, ** = P< 0.001, *** = P<
0.0001.
Studies in the United States in community surveys
over a period of 20 years, from 1971-72 and from
1988-91, showed an increase among hypertensive
patients of awareness of their condition from 51-
84%, and those on treatment from 36-73%. In
contrast, only about a third of Nigerians who are
hypertensive are aware of their condition, and about
2/3 of those who are aware are on treatment .
Among the haematological parameters studied,
prothrombin time, activated partial thromboplastin
time, haemoglobin, packed cell volume, platelet,
erythrocyte sedimentation rate, total white blood cell
count, neutrophil, lymphocyte and monocyte values
showed statistically significant differences (p<0.05)
in the patients when compared with the control group
(table I). This is in line with results of similar
studies that established significant differences
among hypertensive patients, although the
prothrombin time and activated par tia l
thromboplastin time were not studied in these works.
The values obtained in the present work however,
places hypertensive patients as being among the
high-risk group for the detection of coagulation
disorders. This may therefore bear out the need to
routinely screen non-diabetic hypertensive patients
for coagulation parameters/profile.
The blood pressure, height and body mass index
showed statistically significant differences (p<0.05),





between patients and controls (table 1). This
observation is in keeping with the results obtained in
hypertensive Nigerians by Akinkugbe et al, who
reported a strong correlation between the body mass
index and the prevalence of hypertension.
This study has revealed statistically significant
differences in prothrombin time, haemoglobin,
packed cell volume, erythrocyte sedimentation rate,
lymphocyte, eosinophil, monocyte counts and blood
pressure measurements (p<0.05) when male patients
were compared with apparently healthy male controls
(table 2); however, there was no significant
differences in other parameters studied. Furthermore,
the haemoglobin, erythrocyte sedimentation rate,
neutrophil, monocyte, height and body mass index
showed statistically significant differences (p<0.05)
when the female patients were compared with the
female controls (table 3). Although the differences in
prevalence of hypertension among medical
admissions in both sexes (males, 15.4% and females
14.9%) in Eastern Nigeria in a work done at the same
study location, was not significant , the present study
revealed that male non-diabetic hypertensive patients
are more predisposed to coagulation defects than their
corresponding female patients (tables 2 and 3). This
may be attributed to more exerting physical activities,
alcohol consumption, cigarette smoking and lower
level of awareness among male hypertensive patients
as compared to the female hypertensive patients .
Also, lymphocytes, monocyte counts, and body mass
index (BMI) demonstrated statistically significant
differences (p<0.05) between the male and female
patients, with higher levels in the latter. This may be
attributable to the significantly higher BMI values in
females as compared to the males of the same age.
This observation lends itself to further larger
population based study.
Generally, 25 (83.33%) of the non-diabetic
hypertensive patients blood films revealed normal
(normochromic and normocytic) blood picture.
This study has shown that hypertensive patients
present with abnormal prothrombim time, activated
partial thromboplastin time and other haematological
parameters. It is, therefore, being recommended that,
regular routine coagulation studies should be carried
out on hypertensive patients, as part of their clinical
investigation.
Total
mortality and morbidity from heart diseases,
cancer and stroke from 1950-1987 in 27
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